INTERPOL and WHO's IMPACT drug anti-counterfeiting project Pangea II sees seizure of almost 167,000 illicit pills

23 November 2009

An international week of action targeting the on-line sale of counterfeit and illicit medicines has highlighted the dangers of buying such products over the Internet. Due to an ever-increasing number of web sites supplying dangerous and illegal medicines, INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) last week coordinated 24 countries to launch Operation Pangea II.

The operation focused on the three principle components of an illegal web site, the Internet Service Provider (ISP), payment systems and the delivery service. Internationally, more than 16,000 packages were inspected by regulators and customs, resulting in the seizure of nearly 167,000 illicit and counterfeit pills. During the operation, Internet monitoring revealed 751 web sites to be engaged in illegal activity - including offering controlled or prescription-only drugs.

The countries involved in Operation Pangea II were Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Ireland, Israel, Italy, Liechtenstein, Netherlands, New Zealand, Norway, Portugal, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, the UK and the USA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics